PN,31001
SC,0001
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F310A1729710550
OL,3,CAlzheimer's drug rejected for NHS use:
OL,4,CWhat is Donanemab?
OL,6,FAlzheimer's Research UK Executive
OL,7,FDirector Samantha Benham-Hermetz
OL,8,Fjoined Lucrezia in the ITV News studio
OL,9,Fto discuss the "frustrating setback"
OL,11,FA new "effective" Alzheimer's drug has
OL,12,Fbeen rejected for widespread use in
OL,13,Fthe NHS in England after the health
OL,14,Fspending watchdog said it "does not
OL,15,Fcurrently demonstrate value for the
OL,16,FNHS".
OL,26,@vD@[OUxD@DO]
OL,1,W~k4~sj5j5~s1G                    G1/15
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,311,300,200,140,000,100
PN,31002
SC,0002
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F310A1729710550
OL,3,CAlzheimer's drug rejected for NHS use:
OL,4,CWhat is Donanemab?
OL,6,FDescribed as a "frustrating setback"
OL,7,Fby a charity, this is the second
OL,8,FAlzheimer's drug to be rejected by the
OL,9,FNational Institute for Health and Care
OL,10,FExcellence (Nice) in a matter of
OL,11,Fmonths.
OL,13,FThis comes as the Medicines and
OL,14,FHealthcare Products Regulatory Agency
OL,15,F(MHRA) said in August the drug,
OL,16,FDonanemab, manufactured by
OL,17,Fpharmaceutical giant Eli Lilly, could
OL,18,Fbe licensed for use in the UK.
OL,1,W~k4~sj5j5~s1G                    G2/15
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,311,300,200,140,000,100
PN,31003
SC,0003
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F310A1729710550
OL,3,CAlzheimer's drug rejected for NHS use:
OL,4,CWhat is Donanemab?
OL,6,FDonanemab is a targeted antibody drug
OL,7,Fwhich slows the early stages of
OL,8,FAlzheimer's.
OL,10,FAlzheimer's Research UK said Nice's
OL,11,Fannouncement "risks signalling that
OL,12,Fthe UK is no longer a good place to
OL,13,Flaunch new dementia treatments".
OL,15,FThere are concerns that the decision
OL,16,Fcould lead to a two-tier system for
OL,17,FAlzheimer's patients - with those who
OL,18,Fcan afford the drug able to access it
OL,19,Fprivately while those relying on the
OL,20,FNHS left without.
OL,26,@sD@NOUuD@_O]
OL,1,W~k4~sj5j5~s1G                    G3/15
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,311,300,200,140,000,100
PN,31004
SC,0004
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F310A1729710550
OL,3,CAlzheimer's drug rejected for NHS use:
OL,4,CWhat is Donanemab?
OL,6,FDonanemab and another new drug for
OL,7,FAlzheimer's called Lecanemab, have
OL,8,Fbeen reported as a step forward in
OL,9,Fresearch as they target a cause of the
OL,10,Fdisease, rather than just treating
OL,11,Fsymptoms.
OL,13,FAlzheimer's Research UK called the
OL,14,Fdecision "disappointing" and added:
OL,15,F"While these drugs are not cures and
OL,16,Fcome with risk of side-effects, trials
OL,17,Fshow they are the first treatments to
OL,18,Fslow the decline in memory and
OL,19,Fthinking skills linked to Alzheimer's,
OL,20,Frather than just alleviating symptoms.
OL,26,@wD@AOU
OL,1,W~k4~sj5j5~s1G                    G4/15
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,311,300,200,140,000,100
PN,31005
SC,0005
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F310A1729710550
OL,3,CAlzheimer's drug rejected for NHS use:
OL,4,CWhat is Donanemab?
OL,6,F"We've written to the Health Secretary
OL,7,Fagain, calling for his leadership to
OL,8,Fbring together Nice, NHS England and
OL,9,Findustry so that people with dementia
OL,10,Fin the UK aren't left behind."
OL,12,FOn the decision, Nice's director of
OL,13,Fmedicines evaluation, Helen Knight,
OL,14,Fsaid: "For Nice to be able to approve
OL,15,Fa medicine for use in the NHS it must
OL,16,Fprovide additional benefits to
OL,17,Fpatients, and it must also represent a
OL,18,Fgood use of NHS resources and
OL,19,Ftaxpayers' money.
OL,26,@nD@AOUvD@GOU
OL,1,W~k4~sj5j5~s1G                    G5/15
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,311,300,200,140,000,100
PN,31006
SC,0006
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F310A1729710550
OL,3,CAlzheimer's drug rejected for NHS use:
OL,4,CWhat is Donanemab?
OL,6,F"Our independent committee looked at
OL,7,Fall the available evidence, including
OL,8,Fthe benefits for carers. This shows
OL,9,FDonanemab could slow down cognitive
OL,10,Fdecline by four to seven months, but
OL,11,Fthis is just not enough benefit to
OL,12,Fjustify the additional cost to the NHS.
OL,14,F"The cost-effectiveness estimate for
OL,15,FDonanemab is five to six times above
OL,16,Fwhat Nice normally considers an
OL,17,Facceptable use of NHS resources.
OL,26,@nD@AOU
OL,1,W~k4~sj5j5~s1G                    G6/15
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,311,300,200,140,000,100
PN,31007
SC,0007
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F310A1729710550
OL,3,CAlzheimer's drug rejected for NHS use:
OL,4,CWhat is Donanemab?
OL,6,F"I know this will be disappointing
OL,7,Fnews, but this is an emerging field of
OL,8,Fmedicine and other treatments are
OL,9,Fbeing developed."
OL,11,FWhat is Donanemab and how does it work?
OL,13,FBoth Donanemab and Lecanemab are
OL,14,Fantibody drugs that binds to amyloid,
OL,15,Fa protein which builds up in the
OL,16,Fbrains of those with Alzheimer's
OL,17,Fdisease.
OL,19,FBy binding to the protein, the drugs
OL,20,Fhelp clear the build-up and slow
OL,21,Fcognitive decline.
OL,26,@nD@AOUqD@QO]
OL,1,W~k4~sj5j5~s1G                    G7/15
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,311,300,200,140,000,100
PN,31008
SC,0008
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F310A1729710550
OL,3,CAlzheimer's drug rejected for NHS use:
OL,4,CWhat is Donanemab?
OL,6,FTests showed the drug reduced amyloid
OL,7,Fplaque on average by 84% at 18 months,
OL,8,Fmanufacturer Eli Lilly said.
OL,10,FIt can slow the rate at which memory
OL,11,Fand thinking decline by more than 20%.
OL,13,FResults also suggest the drug leads to
OL,14,Fa 40% reduction in the decline of
OL,15,Feveryday activities such as driving,
OL,16,Fenjoying hobbies and managing money.
OL,18,FA retired journalist, Peter Almond,
OL,19,Fwho took part in the clinical trial
OL,20,Ffor the drug said he now feels "as
OL,21,Fnormal as a 78-year-old can be".
OL,26,@|D@`OU}D@_O]
OL,1,W~k4~sj5j5~s1G                    G8/15
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,311,300,200,140,000,100
PN,31009
SC,0009
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F310A1729710550
OL,3,CAlzheimer's drug rejected for NHS use:
OL,4,CWhat is Donanemab?
OL,6,F"I can read, write, think, plan, walk,
OL,7,Fdrive and even run," he said.
OL,9,FHow are the drugs given?
OL,11,FDonanemab is given to patients via an
OL,12,Fintravenous drip once every four weeks.
OL,14,FEli Lilly said some patients can
OL,15,Fcomplete their course of treatment in
OL,16,Fas little as six months once their
OL,17,Famyloid plaque has cleared.
OL,19,FAre there any side effects?
OL,1,W~k4~sj5j5~s1G                    G9/15
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,311,300,200,140,000,100
PN,31010
SC,0010
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F310A1729710550
OL,3,CAlzheimer's drug rejected for NHS use:
OL,4,CWhat is Donanemab?
OL,6,FSide effects of the Donanemab, and
OL,7,Fother similar drugs, can be serious.
OL,9,FDonanemab has been associated with
OL,10,F"amyloid-related imaging abnormalities
OL,11,F(ARIA)," which typically does not
OL,12,Fcause symptoms. However, if it does,
OL,13,Fit can be serious or even fatal.
OL,15,FSymptoms can include temporary brain
OL,16,Fswelling or micro-brain bleeds.
OL,18,FIn one clinical trial published in the
OL,19,FJournal of the American Medical
OL,20,FAssociation in 2023, 24% of people
OL,21,Freceiving Donanemab had Aria.
OL,1,W~k4~sj5j5~s1G                   G10/15
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,311,300,200,140,000,100
PN,31011
SC,0011
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F310A1729710550
OL,3,CAlzheimer's drug rejected for NHS use:
OL,4,CWhat is Donanemab?
OL,6,FEli Lilly recommends that the risk
OL,7,Fshould be managed "with careful
OL,8,Fobservation, monitoring with MRIs, and
OL,9,Fappropriate actions if Aria is
OL,10,Fdetected".
OL,12,FThree deaths were reported among the
OL,13,Fpeople receiving Donanemab during the
OL,14,Ftrial which were considered "treatment-
OL,15,Frelated", according to the 2023 paper.
OL,17,FOne death was reported in the group
OL,18,Fwho received the placebo ` also known
OL,19,Fas a dummy drug.
OL,26,@oD@SOUrD@IO]vD@]OUwD@HO]
OL,1,W~k4~sj5j5~s1G                   G11/15
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,311,300,200,140,000,100
PN,31012
SC,0012
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F310A1729710550
OL,3,CAlzheimer's drug rejected for NHS use:
OL,4,CWhat is Donanemab?
OL,6,FThe majority of side effects (82.4%)
OL,7,Fwere either mild or were detected in
OL,8,Ftests but did not cause any symptoms.
OL,10,FHow much does the drug cost?
OL,12,FEach vial of Donanemab , also known as
OL,13,FKisunla, costs $695.65 (#536.07),
OL,14,Faccording to Eli Lilly.
OL,16,FThe overall cost of Donanemab depends
OL,17,Fon how long the treatment is for each
OL,18,Fperson.
OL,1,W~k4~sj5j5~s1G                   G12/15
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,311,300,200,140,000,100
PN,31013
SC,0013
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F310A1729710550
OL,3,CAlzheimer's drug rejected for NHS use:
OL,4,CWhat is Donanemab?
OL,6,FNHS England has published a briefing
OL,7,Fpaper suggesting the cost of bringing
OL,8,Fnew Alzheimer's disease-modifying
OL,9,Ftreatments to the health service could
OL,10,Fbe #500 million to #1 billion per year.
OL,12,FHow do I know if I am eligible?
OL,14,FNHS England estimates that between
OL,15,F50,000 and 280,000 patients might be
OL,16,Feligible for the drug if it's approved
OL,17,Ffor the NHS.
OL,1,W~k4~sj5j5~s1G                   G13/15
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,311,300,200,140,000,100
PN,31014
SC,0014
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F310A1729710550
OL,3,CAlzheimer's drug rejected for NHS use:
OL,4,CWhat is Donanemab?
OL,6,FPotential eligible patients would need
OL,7,Fto have a baseline MRI scan and then
OL,8,Feither a PET-CT scan or lumbar
OL,9,Fpuncture to confirm Alzheimer's.
OL,11,FWhat have experts said?
OL,13,FWhen clinical trial results were
OL,14,Freported in 2023, some experts said
OL,15,Fthe findings were "incredibly
OL,16,Fencouraging".
OL,18,FOthers have been cautious with
OL,19,Fparticular concerns raised about its
OL,20,Fpotential side effects.
OL,26,@wD@SOUxD@LO]
OL,1,W~k4~sj5j5~s1G                   G14/15
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,311,300,200,140,000,100
PN,31015
SC,0015
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F310A1729710550
OL,3,CAlzheimer's drug rejected for NHS use:
OL,4,CWhat is Donanemab?
OL,6,FSubscribe free to our weekly
OL,7,Fnewsletter for exclusive and original
OL,8,Fcoverage from ITV News. Direct to your
OL,9,Finbox every Friday morning.
OL,1,W~k4~sj5j5~s1G                   G15/15
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,311,300,200,140,000,100
